Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Accounts Payables (2016 - 2025)

Orthopediatrics has reported Accounts Payables over the past 10 years, most recently at $18.8 million for Q4 2025.

  • Quarterly results put Accounts Payables at $18.8 million for Q4 2025, up 110.89% from a year ago — trailing twelve months through Dec 2025 was $18.8 million (up 110.89% YoY), and the annual figure for FY2025 was $18.8 million, up 110.89%.
  • Accounts Payables for Q4 2025 was $18.8 million at Orthopediatrics, up from $7.2 million in the prior quarter.
  • Over the last five years, Accounts Payables for KIDS hit a ceiling of $22.6 million in Q3 2023 and a floor of $7.2 million in Q3 2025.
  • Median Accounts Payables over the past 5 years was $12.7 million (2023), compared with a mean of $13.7 million.
  • Biggest five-year swings in Accounts Payables: tumbled 48.43% in 2024 and later skyrocketed 110.89% in 2025.
  • Orthopediatrics' Accounts Payables stood at $9.3 million in 2021, then increased by 19.57% to $11.2 million in 2022, then grew by 13.44% to $12.6 million in 2023, then fell by 29.58% to $8.9 million in 2024, then skyrocketed by 110.89% to $18.8 million in 2025.
  • The last three reported values for Accounts Payables were $18.8 million (Q4 2025), $7.2 million (Q3 2025), and $12.7 million (Q2 2025) per Business Quant data.